RDOCK: Refinement of rigid-body protein docking predictions

Bioinformatics Program, Boston University, Boston, Massachusetts 02215, USA.
Proteins Structure Function and Bioinformatics (Impact Factor: 2.92). 11/2003; 53(3):693-707. DOI: 10.1002/prot.10460
Source: PubMed

ABSTRACT We present a simple and effective algorithm RDOCK for refining unbound predictions generated by a rigid-body docking algorithm ZDOCK, which has been developed earlier by our group. The main component of RDOCK is a three-stage energy minimization scheme, followed by the evaluation of electrostatic and desolvation energies. Ionic side chains are kept neutral in the first two stages of minimization, and reverted to their full charge states in the last stage of brief minimization. Without side chain conformational search or filtering/clustering of resulting structures, RDOCK represents the simplest approach toward refining unbound docking predictions. Despite its simplicity, RDOCK makes substantial improvement upon the top predictions by ZDOCK with all three scoring functions and the improvement is observed across all three categories of test cases in a large benchmark of 49 non-redundant unbound test cases. RDOCK makes the most powerful combination with ZDOCK2.1, which uses pairwise shape complementarity as the scoring function. Collectively, they rank a near-native structure as the number-one prediction for 18 test cases (37% of the benchmark), and within the top 4 predictions for 24 test cases (49% of the benchmark). To various degrees, funnel-like energy landscapes are observed for these 24 test cases. To the best of our knowledge, this is the first report of binding funnels starting from global searches for a broad range of test cases. These results are particularly exciting, given that we have not used any biological information that is specific to individual test cases and the whole process is entirely automated. Among three categories of test cases, the best results are seen for enzyme/inhibitor, with a near-native structure ranked as the number-one prediction for 48% test cases, and within the top 10 predictions for 78% test cases. RDOCK is freely available to academic users at approximately rong/dock.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Sepsis, a hyperinflammatory response that can result in multiple organ dysfunctions, is a leading cause of mortality from infection. Here, we show that orphan nuclear receptor Nur77 (also known as TR3) can enhance resistance to lipopolysaccharide (LPS)-induced sepsis in mice by inhibiting NF-κB activity and suppressing aberrant cytokine production. Nur77 directly associates with p65 to block its binding to the κB element. However, this function of Nur77 is countered by the LPS-activated p38α phosphorylation of Nur77. Dampening the interaction between Nur77 and p38α would favor Nur77 suppression of the hyperinflammatory response. A compound, n-pentyl 2-[3,5-dihydroxy-2-(1-nonanoyl) phenyl]acetate, screened from a Nur77-biased library, blocked the Nur77-p38α interaction by targeting the ligand-binding domain of Nur77 and restored the suppression of the hyperinflammatory response through Nur77 inhibition of NF-κB. This study associates the nuclear receptor with immune homeostasis and implicates a new therapeutic strategy to treat hyperinflammatory responses by targeting a p38α substrate to modulate p38α-regulated functions.
    Nature Chemical Biology 03/2015; 11(5). DOI:10.1038/nchembio.1788 · 13.22 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Dissimilatory Sulfite Reductase (dSiR) is the main redox enzyme system utilized in sulfur metabolism in both sulfur oxidizing and reducing prokaryotes. Anoxygenic phototrophic bacteria Allochromatium vinosum produces elemental sulfur during sulfur cycle which is ultimately oxidized sulfate by DSR operon. Allochromatium vinosum encodes dsrAB reverse dSiR that oxidizes thiosulfate or elemental sulfur. DsrAB is a α2β2 hetero-tetrameric complex. In our present study, we first reported the three dimensional structure of DsrAB protein complex from Allochromatium vinosum and we also predicted the protein-protein interactions between DsrA and DsrB proteins. DsrAB is a major redox enzyme complex required in both sulfur oxidation and reduction processes so this structure function relationship investigation will help in researches to predict the biochemical mechanism of sulfur-oxidation. The importance of the study lies in the fact that sulfur metabolism pathways are used in waste remediation and bio-hydrogen production. This is the most important aspect of our analysis.
    Second International Conference INDIA 2015, University of Kalyani; 01/2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: A non-peptide inhibitor that is metabolically stable, orally active and capable of crossing the blood–brain barrier has been a popular option for treating Alzheimer's disease (AD). To identify novel non-peptide inhibitors for AD drug development, a structure-based pharmacophore model (SBPM) was developed using the representative docked conformation of the recently discovered peptide inhibitor PGKLVYA in the potential binding site on the Aβ(17–42) protofibril. The best SBPM, consisting of two hydrophobic, one hydrogen bond donor, and one positive ionisable feature, was further validated using ligand pharmacophore mapping studies. The well-validated SBPM was then used as the 3D query in virtual screening to identify potential hits from the National Cancer Institute database. These hits were subsequently filtered by toxicity prediction and molecular docking, and their binding stabilities and affinities were validated by 20-ns molecular dynamics simulations and molecular mechanics Poisson–Boltzmann surface area analysis, respectively. Finally, two Hits (NSC35984 and NSC102747) were identified as potential leads, which exhibited higher binding stability and affinity towards Aβ compared with PGKVYA. Our results also suggest that these two Hits have the ability to prevent Aβ adopting toxic β-sheet structures, and can be easily synthesised and have structural novelty, indicating that they are promising candidates for treating AD.
    Molecular Simulation 12/2014; 41(8):1-11. DOI:10.1080/08927022.2014.910600 · 1.12 Impact Factor


1 Download
Available from